Overview and Scope
The kidney biopsy market consists of revenues earned by entities by providing services such as diagnostic biopsy, therapeutic biopsy, post-biopsy care and monitoring, and pathological analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The kidney biopsy market also includes sales of biopsy needles, biopsy guns, biopsy trays and kits, and biopsy specimen containers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Sizing and Forecast
The kidney biopsy market size has grown strongly in recent years. It will grow from $2.03 billion in 2023 to $2.14 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to increased chronic kidney diseases, rise in awareness about early diagnosis, surge in geriatric population, expansion of healthcare infrastructure, enhanced government initiatives for kidney disease management, and rise in awareness of kidney health.
The kidney biopsy market size is expected to see strong growth in the next few years. It will grow to $2.66 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to increasing prevalence of kidney diseases, rising healthcare expenditure, growing awareness about early diagnosis, expanding geriatric population, rising demand for minimally invasive procedures, and increasing research activities. Major trends in the forecast period include technological advancements in biopsy techniques, adoption of minimally invasive procedures, advancements in imaging technologies, integration of artificial intelligence for better precision, and technological innovations in biopsy devices.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report
Segmentation & Regional Insights
The kidney biopsy market covered in this report is segmented –
1) By Type: Percutaneous Biopsy, Surgical Biopsy
2) By Indication: Kidney Failure, Kidney Transplant, Hematuria, Proteinuria
3) By End-User: Hospitals And Clinics, Urology Centers, Tertiary Care Centers, Other End-Users
North America was the largest region in the kidney biopsy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp
Major Driver Impacting Market Growth
The rise in the incidence of renal cancer is expected to propel the growth of the kidney biopsy market going forward. Renal cancer is characterized by the uncontrolled growth of abnormal kidney cells. The rise in renal cancer is attributed to factors such as changes in lifestyle, environmental toxins, and better detection techniques that result in more diagnoses. A kidney biopsy helps diagnose and manage renal cancer by confirming the presence of cancerous cells, determining cancer grade, planning treatment, monitoring treatment response, and providing prognostic information. For instance, according to Cancer Research UK, a UK-based cancer research organization, the new kidney cancer cases are expected to increase from approximately 16,300 in 2023 to about 21,900 in 2025. Therefore, the rise in the incidence of renal cancer is driving the growth of the kidney biopsy market.
Key Industry Players
Major companies operating in the kidney biopsy market are Cardinal Health, Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca , Medtronic, Siemens Healthcare Private Limited, Becton, Dickinson and Company, Strykar Healthcare, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., Zimmer Biomet, Agilent Technologies Inc., Olympus Corporation, Hitachi High-Tech Corporation, Beckman Coulter Inc. , B. Braun, Sysmex Corporation, Cook Medical, Bio-Rad Laboratories Inc., Integra LifeSciences Corporation, Merit Medical Systems, Leica Biosystems Nussloch GmbH, Argon Medical Devices Inc., BioGenex
The kidney biopsy market report table of contents includes:
1. Executive Summary
2. Kidney Biopsy Market Characteristics
3. Kidney Biopsy Market Trends And Strategies
4. Kidney Biopsy Market – Macro Economic Scenario
5. Global Kidney Biopsy Market Size and Growth
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the trending research reports from TBRC:
https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report
https://www.thebusinessresearchcompany.com/report/kidney-transplant-global-market-report
https://www.thebusinessresearchcompany.com/report/artificial-kidney-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
